Pharmacists in all areas of practice frequently dispense or recommend drugs without realizing that some commonly used medications have never received Food and Drug Administration (FDA) approval. Most of these medications have been available for many years and are usually misconceived as generic drugs, when in fact they never went through the required quality, safety, and efficacy testing required by FDA. As a result, unapproved drugs can pose serious safety risks to patients and create uncertainty in the market. FDA established the ‘‘Unapproved Drugs Initiative’ ’ to protect public health by decreasing the number of available unapproved drugs with minimal disruptions to the market. Unapproved drugs remain in the market for various historica...
Posted with permission from FDLI ; Food and Drug Law Journal Various proposals have been advanced in...
A letter report issued by the Government Accountability Office with an abstract that begins "In the ...
In May 2005, the Food and Drug Administration (FDA) issued draft guidance on the type of information...
Pharmacists in all areas of practice frequently dispense or recommend drugs without realizing that s...
(FDA) announced the publication of the agency’s final Compliance Policy Guide (CPG) concerning its r...
Modern medicine faces many significant problems. This Article is about two of them. The first is tha...
Modern medicine faces many significant problems. This Article is about two of them. The first is tha...
oai:ojs2.ijistweb.com:article/1New drug is the one which is not previously available and intended to...
The US Food and Drug Administration (FDA) is developing a new framework to provide patients with qua...
Physicians often prescribe prescription drugs and other medications for uses that are not approved b...
Iran. Detection of adverse drug reactions (ADRs) in hospitals provides an important measure of the b...
T he current Food and Drug Administration (FDA) system of regulating drug safety hasserious limitati...
Journal Article;BACKGROUND In Spain, hospital medicines are assessed and selected by local Pharmacy...
Background: Access to essential drugs and up-to-date information related to drugs are critical for o...
Abstract The safe and effective use of medicines is an inte-gral part of the medicine safety agenda....
Posted with permission from FDLI ; Food and Drug Law Journal Various proposals have been advanced in...
A letter report issued by the Government Accountability Office with an abstract that begins "In the ...
In May 2005, the Food and Drug Administration (FDA) issued draft guidance on the type of information...
Pharmacists in all areas of practice frequently dispense or recommend drugs without realizing that s...
(FDA) announced the publication of the agency’s final Compliance Policy Guide (CPG) concerning its r...
Modern medicine faces many significant problems. This Article is about two of them. The first is tha...
Modern medicine faces many significant problems. This Article is about two of them. The first is tha...
oai:ojs2.ijistweb.com:article/1New drug is the one which is not previously available and intended to...
The US Food and Drug Administration (FDA) is developing a new framework to provide patients with qua...
Physicians often prescribe prescription drugs and other medications for uses that are not approved b...
Iran. Detection of adverse drug reactions (ADRs) in hospitals provides an important measure of the b...
T he current Food and Drug Administration (FDA) system of regulating drug safety hasserious limitati...
Journal Article;BACKGROUND In Spain, hospital medicines are assessed and selected by local Pharmacy...
Background: Access to essential drugs and up-to-date information related to drugs are critical for o...
Abstract The safe and effective use of medicines is an inte-gral part of the medicine safety agenda....
Posted with permission from FDLI ; Food and Drug Law Journal Various proposals have been advanced in...
A letter report issued by the Government Accountability Office with an abstract that begins "In the ...
In May 2005, the Food and Drug Administration (FDA) issued draft guidance on the type of information...